Findley HW - Search Results

1

DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.

Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW. Zhou M, et al. Among authors: findley hw. J Pharmacol Exp Ther. 2002 Oct;303(1):124-31. doi: 10.1124/jpet.102.037192. J Pharmacol Exp Ther. 2002. PMID: 12235242

2

MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.

Gu L, Findley HW, Zhou M. Gu L, et al. Among authors: findley hw. Blood. 2002 May 1;99(9):3367-75. doi: 10.1182/blood.v99.9.3367. Blood. 2002. PMID: 11964305 Free article.

3

PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.

Zhou M, Gu L, Findley HW, Jiang R, Woods WG. Zhou M, et al. Among authors: findley hw. Cancer Res. 2003 Oct 1;63(19):6357-62. Cancer Res. 2003. PMID: 14559824

4

Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53.

Zhou M, Gu L, Zhu N, Woods WG, Findley HW. Zhou M, et al. Among authors: findley hw. Oncogene. 2003 Nov 6;22(50):8137-44. doi: 10.1038/sj.onc.1206911. Oncogene. 2003. PMID: 14603254

5

An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.

Zhu N, Gu L, Findley HW, Li F, Zhou M. Zhu N, et al. Among authors: findley hw. Oncogene. 2004 Sep 30;23(45):7545-51. doi: 10.1038/sj.onc.1208038. Oncogene. 2004. PMID: 15334064

6

Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.

Gu L, Zhu N, Findley HW, Woods WG, Zhou M. Gu L, et al. Among authors: findley hw. J Biol Chem. 2004 Dec 10;279(50):52141-9. doi: 10.1074/jbc.M407915200. Epub 2004 Oct 5. J Biol Chem. 2004. PMID: 15469934 Free article.

7

Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.

Zhu N, Gu L, Findley HW, Zhou M. Zhu N, et al. Among authors: findley hw. Biochem Biophys Res Commun. 2005 Oct 7;335(4):1272-9. doi: 10.1016/j.bbrc.2005.08.026. Biochem Biophys Res Commun. 2005. PMID: 16112647

8

KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia.

Zhu N, Gu L, Findley HW, Chen C, Dong JT, Yang L, Zhou M. Zhu N, et al. Among authors: findley hw. J Biol Chem. 2006 May 26;281(21):14711-8. doi: 10.1074/jbc.M513810200. Epub 2006 Apr 4. J Biol Chem. 2006. PMID: 16595680 Free article.

9

Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.

Gu L, Chiang KY, Zhu N, Findley HW, Zhou M. Gu L, et al. Among authors: findley hw. Exp Hematol. 2007 Jun;35(6):957-66. doi: 10.1016/j.exphem.2007.03.007. Exp Hematol. 2007. PMID: 17533050 Clinical Trial.

10

Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia.

Findley HW, Gu L, Yeager AM, Zhou M. Findley HW, et al. Blood. 1997 Apr 15;89(8):2986-93. Blood. 1997. PMID: 9108419 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters